Qinong Ye Selected Research

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)

7/2021	A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.
1/2019	Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis.
10/2015	Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
3/2015	HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
10/2013	HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition.
2/2013	Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qinong Ye Research Topics

Disease

49	Neoplasms (Cancer) 05/2022 - 03/2004
30	Breast Neoplasms (Breast Cancer) 07/2021 - 09/2003
13	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2013
10	Carcinogenesis 03/2020 - 12/2004
9	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2006
6	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 07/2021 - 02/2013
5	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2012
3	Osteoarthritis 01/2019 - 01/2016
3	Hypoxia (Hypoxemia) 06/2018 - 11/2012
3	Liver Neoplasms (Liver Cancer) 10/2013 - 02/2013
3	Infections 03/2013 - 01/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2022 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2017
1	Adenocarcinoma of Lung 01/2022
1	Melanoma (Melanoma, Malignant) 03/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Adenocarcinoma 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Poisoning 01/2018

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 07/2021 - 03/2004
19	Transcription Factors (Transcription Factor)IBA 07/2021 - 12/2005
11	Estrogen ReceptorsIBA 01/2019 - 12/2005
8	Small Interfering RNA (siRNA)IBA 01/2022 - 07/2009
8	MicroRNAs (MicroRNA)IBA 12/2020 - 02/2013
7	1,1-dimethyl-4-acetylpiperaziniumIBA 07/2021 - 06/2008
6	EnzymesIBA 01/2022 - 06/2013
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2017
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2012
5	Messenger RNA (mRNA)IBA 01/2019 - 09/2003
5	Biological ProductsIBA 01/2018 - 01/2006
5	Estrogens (Estrogen)FDA Link 08/2013 - 06/2008
5	Estrogen Receptor alphaIBA 06/2008 - 09/2003
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2012
4	Cyclin B1IBA 10/2015 - 09/2011
3	Long Noncoding RNAIBA 01/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2017
3	Cyclin D1IBA 10/2015 - 09/2011
3	Estrogen Receptor betaIBA 06/2008 - 12/2005
2	Histones (Histone)IBA 01/2022 - 03/2016
2	Oncogene Proteins (Oncogene Protein)IBA 07/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 07/2021 - 08/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 12/2020 - 01/2017
2	LigandsIBA 01/2020 - 12/2005
2	Tyrosine (L-Tyrosine)FDA Link 07/2016 - 08/2014
2	ChromatinIBA 04/2016 - 03/2004
2	CytokinesIBA 01/2016 - 03/2013
2	Cyclin AIBA 10/2015 - 06/2012
2	AgarIBA 09/2015 - 07/2015
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2015 - 12/2004
2	hepatitis B virus X proteinIBA 02/2013 - 01/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 02/2009 - 03/2004
1	Sunitinib (Sutent)FDA Link 05/2022
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	lactate dehydrogenase 1 (LDH1)IBA 01/2022
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2022
1	LipidsIBA 10/2021
1	RimonabantIBA 07/2021
1	Pharmaceutical PreparationsIBA 07/2021
1	Green Fluorescent ProteinsIBA 07/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2021
1	RibonucleoproteinsIBA 06/2021
1	JNK Mitogen-Activated Protein KinasesIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Glucose-6-PhosphateIBA 01/2021
1	PhosphoglucomutaseIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	cytochrome P-450 CYP4B1 (CYP4B1)IBA 01/2021
1	glucose-1-phosphateIBA 01/2021
1	N-methyladenosineIBA 01/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2020
1	Ligases (Synthetase)IBA 10/2020
1	UbiquitinIBA 10/2020
1	3' Untranslated Regions (3' UTR)IBA 03/2020
1	acetyl-LDLIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	Oleic Acid (Oleate)IBA 01/2020
1	AntibodiesIBA 01/2020
1	AcidsIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	AminophenolsIBA 01/2019
1	Hair DyesIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019
1	CholesterolIBA 01/2019
1	GATA Transcription FactorsIBA 01/2019
1	Endocrine DisruptorsIBA 01/2019
1	Recombinant ProteinsIBA 06/2018
1	AdipokinesIBA 01/2018
1	src-Family KinasesIBA 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018

Therapy/Procedure

18	Therapeutics 05/2022 - 12/2005
1	Drug Therapy (Chemotherapy) 01/2019